Vertus Life Sciences Private Limited

Vertus Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24110TG2020PTC143888 Incorporated 14 September 2020 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹37.53 Lakh
▼ 90% YoY
Net loss · FY 2025
₹22.05 Lakh
Net margin -58.8%
EBITDA · FY 2025
₹10.45 Lakh
EBITDA margin 27.8%
Authorised capital
₹60 Lakh
Registered with MCA
Paid-up capital
₹51 Lakh
Issued & subscribed
Open charges
₹2 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings

About Vertus Life Sciences Private Limited

Data last updated:

Vertus Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 September 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2020PTC143888. Its GSTIN is 36AAHCV6039Q1ZJ (Telangana).

The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹51 Lakh. It is led by directors Prasanth Manne (Managing Director) and Nishita Nadella.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mig – 172 Road No 1 Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500085.

As per the financials filed for FY 2025, the company reported a revenue of ₹37.53 Lakh, a decline of 90% compared to the previous year. For the same year it recorded a net loss of ₹22.05 Lakh (net margin -58.8%) and EBITDA of ₹10.45 Lakh (EBITDA margin 27.8%). Revenue has declined at a compounded annual rate (CAGR) of 31% over three years.

As per MCA filings, the company has open charges of ₹2 Cr on record.

Vertus Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0019073).

Company details

CIN U24110TG2020PTC143888
Registration Number 143888
Incorporation Date 14 September 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0019073

Recognitions & Rankings of Vertus Life Sciences

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-20-0019073

Contact details

Vertus Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Mig – 172 Road No 1 Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500085
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Vertus Life Sciences Private Limited, buy the company report.

Comprehensive company report
Vertus Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Vertus Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Vertus Life Sciences Private Limited, buy the company report.

Financials of Vertus Life Sciences Private Limited

FY 2025 filings available

Vertus Life Sciences Private Limited reported revenue of ₹37.53 Lakh (down 90% YoY) for FY 2025.

Revenue · FY 2025
₹37.53 Lakh ▼ 90%
Net loss · FY 2025
₹22.05 Lakh margin -58.8%
EBITDA · FY 2025
₹10.45 Lakh margin 27.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 90%
3 years · compounded
▼ 31%
EBITDA CAGR growth
1 year
▲ 129%
3 years · compounded
▲ 12%

Revenue has declined at a compounded annual rate (CAGR) of 31% over three years, including a 90% fall in the latest year. EBITDA rose 129% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.45 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹22.05 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin27.8%
Net Profit Margin-58.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Vertus Life Sciences Private Limited, buy the company report.

Board of directors of Vertus Life Sciences Private Limited

Vertus Life Sciences has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Nishita NadellaDirector14 Sep 20206 Years 1 MonthsCurrent
Prasanth ManneManaging Director14 Sep 20206 Years 1 MonthsCurrent

Auditor

Vertus Life Sciences Private Limited is audited by S.KASTHURI RENGAN & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
S.KASTHURI RENGAN & COFY 2023008084S

Shareholding

The shareholding of Vertus Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Vertus Life Sciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2 Cr
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹2.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Nov 2021100499772State Bank of India₹2 CrOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Vertus Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Vertus Life Sciences Private Limited has 1 active EPFO establishment as of Apr 06, 2024.

Active EPFO establishments
1

GST

Vertus Life Sciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAHCV6039Q1ZJTelanganaActive29 Jul 2021

To see the full GST registrations and return filing status of Vertus Life Sciences Private Limited, buy the company report.

Recent activity

Vertus Life Sciences Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Nishita Nadella was appointed as Director on 14 Sep 2020.

AGM
Vertus Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vertus Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with State Bank Of India amounted to Rs. 200.00 Lakh with Charge ID 100499772 was registered on 18 Nov 2021.
Appointed
Nishita Nadella was appointed as Director.
Appointed
Prasanth Manne was appointed as Managing Director.
Incorporation
14 Sep 2020
Vertus Life Sciences Private Limited was registered on 14 Sep 2020 with Roc Hyderabad & aged 6 years 1 month as per MCA records.

Frequently asked questions

Vertus Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 September 2020 (6+ years old) and is registered under CIN U24110TG2020PTC143888.

Vertus Life Sciences has 2 current directors:

The latest financial statements of Vertus Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Vertus Life Sciences is 36AAHCV6039Q1ZJ, registered in Telangana.

The CIN (Corporate Identification Number) of Vertus Life Sciences is U24110TG2020PTC143888. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Vertus Life Sciences was incorporated on 14 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.

Nishita Nadella was appointed as Director on 14 Sep 2020. Prasanth Manne was appointed as Managing Director on 14 Sep 2020.

Yes, Vertus Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0019073).

The registered office of Vertus Life Sciences is at Mig – 172 Road No 1 Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500085.

Vertus Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.